As of 31 March 2022, 15 authorities had a requirement for all licensed taxis to have CCTV fitted and 14 had a requirement for all licensed PHVs to have CCTV fitted.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4813", "label" : {"_value" : "Biography information for Mr Richard Holden"} } , "answeringMemberConstituency" : {"_value" : "North West Durham"} , "answeringMemberPrinted" : {"_value" : "Mr Richard Holden"} , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-30T08:20:04.007Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "27"} , "answeringDeptShortName" : {"_value" : "Transport"} , "answeringDeptSortName" : {"_value" : "Transport"} , "date" : {"_value" : "2023-03-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Taxis: CCTV"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Transport, how many licensing authorities have introduced mandatory CCTV in (a) taxis and (b) private hire vehicles.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "174319"} , {"_about" : "http://data.parliament.uk/resources/1608018", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1608018/answer", "answerText" : {"_value" : "
The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme for branded medicines pricing and access (VPAS) upon the different organisations represented and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 VPAS. In order to facilitate a transparent and candid discussion, participants agreed that all contributions and resulting outputs would be kept confidential to those who attended.<\/p>
The following organisations were invited to the workshops:<\/p>
Industry bodies (including representatives of their member companies):<\/p>
- Association of the British Pharmaceutical Industry;<\/p>
- British Generic Manufacturers Association;<\/p>
- Ethical Medicines Industry Group;<\/p>
- BioIndustry Association.<\/p>
Patient organisations and civil society organisations:<\/p>
- Cancer52;<\/p>
- The Blood Cancer Alliance;<\/p>
- The Charity Medicines Access Coalition;<\/p>
- National Voices;<\/p>
- The Patients Association;<\/p>
- Alzheimer\u2019s Research UK;<\/p>
- Anthony Nolan;<\/p>
- Cystic Fibrosis Trust;<\/p>
- Genetic Alliance UK;<\/p>
- The Association of Medical Research Charities;<\/p>
- Breast Cancer Now;<\/p>
- Myeloma UK;<\/p>
- Office of Health Economics;<\/p>
- King\u2019s Fund;<\/p>
- NHS Confederation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "174321"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-30T15:18:28.87Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access: Disclosure of Information"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to his Department\u2019s ongoing VPAS pre-negotiation workshops, if he will publish the (a) minutes and (b) attendees of those workshops.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "174320"} , {"_about" : "http://data.parliament.uk/resources/1608020", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1608020/answer", "answerText" : {"_value" : "
The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme for branded medicines pricing and access (VPAS) upon the different organisations represented and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 VPAS. In order to facilitate a transparent and candid discussion, participants agreed that all contributions and resulting outputs would be kept confidential to those who attended.<\/p>
The following organisations were invited to the workshops:<\/p>
Industry bodies (including representatives of their member companies):<\/p>
- Association of the British Pharmaceutical Industry;<\/p>
- British Generic Manufacturers Association;<\/p>
- Ethical Medicines Industry Group;<\/p>
- BioIndustry Association.<\/p>
Patient organisations and civil society organisations:<\/p>
- Cancer52;<\/p>
- The Blood Cancer Alliance;<\/p>
- The Charity Medicines Access Coalition;<\/p>
- National Voices;<\/p>
- The Patients Association;<\/p>
- Alzheimer\u2019s Research UK;<\/p>
- Anthony Nolan;<\/p>
- Cystic Fibrosis Trust;<\/p>
- Genetic Alliance UK;<\/p>
- The Association of Medical Research Charities;<\/p>
- Breast Cancer Now;<\/p>
- Myeloma UK;<\/p>
- Office of Health Economics;<\/p>
- King\u2019s Fund;<\/p>
- NHS Confederation.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"} } , "answeringMemberConstituency" : {"_value" : "Colchester"} , "answeringMemberPrinted" : {"_value" : "Will Quince"} , "dateOfAnswer" : {"_value" : "2023-03-30", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "174320"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2023-03-30T15:18:28.937Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2023-03-27", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access: Disclosure of Information"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, with reference to his Department\u2019s ongoing VPAS pre-negotiation workshops, whether he plans to make the outputs of those discussions publicly available.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"} } , "tablingMemberConstituency" : {"_value" : "Cambridge"} , "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"} ], "uin" : "174321"} , {"_about" : "http://data.parliament.uk/resources/1604862", "AnsweringBody" : [{"_value" : "Cabinet Office"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1604862/answer", "answerText" : {"_value" : "
This information is not held centrally.<\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4613", "label" : {"_value" : "Biography information for Alex Burghart"}
}
, "answeringMemberConstituency" : {"_value" : "Brentwood and Ongar"}
, "answeringMemberPrinted" : {"_value" : "Alex Burghart"}
, "dateOfAnswer" : {"_value" : "2023-03-28", "_datatype" : "dateTime"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-03-28T12:39:40.177Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "53"}
, "answeringDeptShortName" : {"_value" : "Cabinet Office"}
, "answeringDeptSortName" : {"_value" : "Cabinet Office"}
, "date" : {"_value" : "2023-03-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Government Departments: Contracts"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Minister for the Cabinet Office, how many outsourcing contracts the Government has in place broken down by (a) central Government, (b) defence, (c) the NHS, (d) local government, (e) schools and (f) wider education; and what the total value is of those contracts by each category.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "167134"}
, {"_about" : "http://data.parliament.uk/resources/1604911", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1604911/answer", "answerText" : {"_value" : " The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme upon the different organisations represented, and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 voluntary scheme for branded medicines pricing and access. In order to facilitate a transparent and candid discussion, participants agreed that all contributions would be kept confidential to those who attended.<\/p> The following external organisations were invited to the workshops:<\/p> Industry bodies:<\/p> - Association of the British Pharmaceutical Industry<\/p> - British Generic Manufacturers Association<\/p> - Ethical Medicines Industry Group<\/p> - BioIndustry Association<\/p> Patient organisations and civil society organisations:<\/p> - Cancer52<\/p> - The Blood Cancer Alliance<\/p> - The Charity Medicines Access Coalition<\/p> - National Voices<\/p> - The Patients Association<\/p> - Alzheimer\u2019s Research UK<\/p> - Anthony Nolan<\/p> - Cystic Fibrosis Trust<\/p> - Genetic Alliance UK<\/p> - The Association of Medical Research Charities<\/p> - Breast Cancer Now<\/p> - Myeloma UK<\/p> - Office of Health Economics<\/p> - King\u2019s Fund<\/p> - NHS Confederation<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-03-23", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "167136"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-03-23T16:20:08.66Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-03-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, if he will publish (a) the minutes from and (b) a list of attendees at the workshops his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "167135"}
, {"_about" : "http://data.parliament.uk/resources/1604912", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1604912/answer", "answerText" : {"_value" : " The objective of the pre-negotiation workshops was to enable a mutual understanding of the impact of the current voluntary scheme upon the different organisations represented, and to discuss the potential objectives and priorities for a new voluntary scheme. The discussions in the workshops will feed into the upcoming negotiation of a successor to the 2019 voluntary scheme for branded medicines pricing and access. In order to facilitate a transparent and candid discussion, participants agreed that all contributions would be kept confidential to those who attended.<\/p> The following external organisations were invited to the workshops:<\/p> Industry bodies:<\/p> - Association of the British Pharmaceutical Industry<\/p> - British Generic Manufacturers Association<\/p> - Ethical Medicines Industry Group<\/p> - BioIndustry Association<\/p> Patient organisations and civil society organisations:<\/p> - Cancer52<\/p> - The Blood Cancer Alliance<\/p> - The Charity Medicines Access Coalition<\/p> - National Voices<\/p> - The Patients Association<\/p> - Alzheimer\u2019s Research UK<\/p> - Anthony Nolan<\/p> - Cystic Fibrosis Trust<\/p> - Genetic Alliance UK<\/p> - The Association of Medical Research Charities<\/p> - Breast Cancer Now<\/p> - Myeloma UK<\/p> - Office of Health Economics<\/p> - King\u2019s Fund<\/p> - NHS Confederation<\/p> <\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4423", "label" : {"_value" : "Biography information for Will Quince"}
}
, "answeringMemberConstituency" : {"_value" : "Colchester"}
, "answeringMemberPrinted" : {"_value" : "Will Quince"}
, "dateOfAnswer" : {"_value" : "2023-03-23", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "167135"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "questionFirstAnswered" : [{"_value" : "2023-03-23T16:20:08.707Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2023-03-16", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Voluntary Scheme for Branded Medicines Pricing and Access"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, whether he plans to publish information about the outcomes from the workshops that his Department has been running ahead of negotiations on a new Voluntary Scheme for Branded Medicines Pricing and Access.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/4382", "label" : {"_value" : "Biography information for Daniel Zeichner"}
}
, "tablingMemberConstituency" : {"_value" : "Cambridge"}
, "tablingMemberPrinted" : [{"_value" : "Daniel Zeichner"}
], "uin" : "167136"}
, {"_about" : "http://data.parliament.uk/resources/1604997", "AnsweringBody" : [{"_value" : "Cabinet Office"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1604997/answer", "answerText" : {"_value" : " This information is not held centrally<\/p>